Nikola Biller-Andorno discusses prediction markets in clinical research on BBC World Service
In an interview for the BBC World Service programme Health Check, Professor Nikola Biller-Andorno discusses the ethical implications of new prediction markets that allow people to trade on clinical-trial outcomes and decisions by the US Food and Drug Administration.
The interview considers whether such markets could provide useful public forecasts, but also examines risks involving conflicts of interest, non-public information, patient expectations, research funding and public trust. It asks a broader question: should uncertainty in clinical research become another opportunity for financial speculation?
The interview was first broadcast on 29 July 2026.